← Leaderboards
Vijayakumar Velu
Emory University
$8,193,463
Attributed
$12,759,005
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2014–25$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,759,005 · 6
By mechanism
R01$7,628,021 · 3
U19$3,685,755 · 1
R56$927,200 · 1
U54$518,029 · 1
Top collaborators
- Rama Rao Amara5 shared
- Stephen N. Waggoner3 shared
- Anthony T Podany2 shared
- Francois J Villinger2 shared
Most similar at Emory University
Same institution · by research overlap
- Rama Rao Amara$90,840,294
- Francois J Villinger$61,853,654
- Harriet L Robinson$13,479,393
- Siddappa N Byrareddy$14,019,085
- Guido Silvestri$61,186,493
Others in their field
Top investigators on “Immune”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$541,067,641
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$470,748,611
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Judith S. Currier · University Of California Los Angeles$334,425,492
Research focus
ImmuneMacaca MulattaVaccinationMacacaViralResponseInfectionImmunityIn VitroSimian Human Immunodeficiency VirusAnimalsSafetyNatural Killer CellsSiv VaccinesMorbidity - Disease RateCellsBloodT-LymphocyteAdjuvantTnfsf5 GeneHiv InfectionsIn VivoHelper-Inducer T-LymphocyteB-Lymphocytes
Grant awards (16)
IL-15 Therapy Combined with TGF-Beta Blockade for Sustained HIV Remission$800,389
R01 · FY2025 · AI · contact PI
Blocking granzyme-mediated immune suppression to enhance HIV vaccine efficacy$556,715
R01 · FY2025 · AI
Project 3: Dynamics of Immune Signatures and Microbiome in Patients with Cervical Pre-Cancer and Cancer Among Women.$518,029
U54 · FY2025 · CA · contact PI
IL-15 Therapy Combined with TGF-Beta Blockade for Sustained HIV Remission$927,200
R56 · FY2024 · AI · contact PI
Combined cytokine therapy for sustained HIV remission$892,227
R01 · FY2024 · AI · contact PI
Blocking granzyme-mediated immune suppression to enhance HIV vaccine efficacy$833,010
R01 · FY2024 · AI
Combined cytokine therapy for sustained HIV remission$1,021,416
R01 · FY2023 · AI · contact PI
Blocking granzyme-mediated immune suppression to enhance HIV vaccine efficacy$851,001
R01 · FY2023 · AI
Combined cytokine therapy for sustained HIV remission$891,222
R01 · FY2022 · AI · contact PI
Combined cytokine therapy for sustained HIV remission$890,185
R01 · FY2021 · AI · contact PI
Combined cytokine therapy for sustained HIV remission$891,856
R01 · FY2020 · AI · contact PI
Macaque Core -Core B$670,814
U19 · FY2018 · AI · contact PI
Macaque Core -Core B$711,797
U19 · FY2017 · AI · contact PI
Macaque Core -Core B$960,730
U19 · FY2016 · AI · contact PI
Macaque Core -Core B$664,042
U19 · FY2015 · AI · contact PI
Macaque Core -Core B$678,372
U19 · FY2014 · AI · contact PI